<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03128580</url>
  </required_header>
  <id_info>
    <org_study_id>1703-VLC-021-EL</org_study_id>
    <nct_id>NCT03128580</nct_id>
  </id_info>
  <brief_title>Embryo Aneuploidies and Morphokinetics in Ovarian Stimulated and Non Stimulated IVF Cycles</brief_title>
  <acronym>AMOS</acronym>
  <official_title>Embryo Aneuploidies and Morphokinetics in Ovarian Stimulated and Non Stimulated Cycles. An Intrapatient Comparison Using Next Generation Sequencing in Biopsy of Blastocysts and Time Lapse Evaluation.</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Instituto Valenciano de Infertilidad, IVI VALENCIA</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Instituto Valenciano de Infertilidad, IVI VALENCIA</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to compare the number of euploid embryos obtained per metaphase&#xD;
      II oocyte in unstimulated (modified natural cycles) and stimulated IVF cycles.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Effects of ovarian stimulation on human embryo quality is still a subject of study. When&#xD;
      natural and stimulated cycles have been compared, no differences have been observed in terms&#xD;
      of embryo cleavage capacity, oocyte and embryo aneuploidy rate or incidence of aneuploidy in&#xD;
      aborted foetuses. When mild and conventional doses of gonadotropins have been compared, a&#xD;
      higher proportion of good morphological quality embryos are observed in the former. On the&#xD;
      contrary, we showed that ovarian stimulation does not increase significantly the embryo&#xD;
      aneuploidy rate in IVF derived human embryos when unstimulated and stimulated cycles were&#xD;
      compared in oocyte donors. In this study, we want to compare the embryo aneuploidy rate&#xD;
      between unstimulated and stimulated cycles in infertile patients, subjected to both IVF&#xD;
      cycles with blastocyst biopsy and NGS-PGS. A comparison of the morphokinetics will also be&#xD;
      performed.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Terminated</overall_status>
  <why_stopped>
    After an interim analysis, it was decided to discontinue the study after a stochastic&#xD;
    curtailment analysis.&#xD;
  </why_stopped>
  <start_date type="Actual">April 21, 2017</start_date>
  <completion_date type="Actual">July 3, 2020</completion_date>
  <primary_completion_date type="Actual">April 7, 2020</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Comparison of the number of euploid embryos from Metaphase II oocytes in different cohorts of embryos.</measure>
    <time_frame>30 days</time_frame>
    <description>Number of metaphase II oocyte per euploid embryo in unstimulated and stimulated cycles.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Incidence of embryo aneuploidies in two cohorts of embryos.</measure>
    <time_frame>30 days</time_frame>
    <description>Incidence of embryo aneuploidies between the unstimulated and stimulated cycle in the same patient</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Morphokinetic evaluation of embryos in two different cohorts of embryos.</measure>
    <time_frame>30 days</time_frame>
    <description>Morphokinetic evaluation of the embryos obtained in an unstimulated and stimulated cycle</description>
  </secondary_outcome>
  <number_of_groups>2</number_of_groups>
  <enrollment type="Actual">40</enrollment>
  <condition>Euploid Embryos</condition>
  <arm_group>
    <arm_group_label>Natural Cycle</arm_group_label>
    <description>The patient will not undergo hyperstimulation rather a natural cycle</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Stimulated Cycle</arm_group_label>
    <description>The 80 patients will undergo hyperstimulation cycle as per the clinical practice planned for the patient.</description>
  </arm_group>
  <eligibility>
    <study_pop>
      <textblock>
        Women undergoing In Vitro Fertilization treatment&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Women&#xD;
&#xD;
          -  30-38 years old (inclusive)&#xD;
&#xD;
          -  with regular menstrual cycles (25-35 days)&#xD;
&#xD;
          -  AntiMÃ¼lleriana Hormone &gt;5 pmol/L.&#xD;
&#xD;
          -  Undergoing IVF treatment&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  BMI &gt;30 kg/m2&#xD;
&#xD;
          -  repeated miscarriages&#xD;
&#xD;
          -  implantation failure&#xD;
&#xD;
          -  uterine or adnexal pathology&#xD;
&#xD;
          -  Unable to be treated with gonadotrophins for the ovarian hyperstimulation&#xD;
&#xD;
          -  history of low response to ovarian hyperstimulation&#xD;
&#xD;
          -  participation in another study with PGS for monogenic pathology&#xD;
&#xD;
          -  Cryptozoospermia in male partner&#xD;
      </textblock>
    </criteria>
    <gender>Female</gender>
    <gender_based>Yes</gender_based>
    <gender_description>Women undergoing fertility treatment</gender_description>
    <minimum_age>30 Years</minimum_age>
    <maximum_age>38 Years</maximum_age>
  </eligibility>
  <location>
    <facility>
      <name>IVI Valencia</name>
      <address>
        <city>Valencia</city>
        <zip>46003</zip>
        <country>Spain</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Instituto Valenciano de Infertilidad Spain</name>
      <address>
        <city>Valencia</city>
        <zip>46015</zip>
        <country>Spain</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>IVI Valencia</name>
      <address>
        <city>Valencia</city>
        <zip>46015</zip>
        <country>Spain</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Spain</country>
  </location_countries>
  <verification_date>July 2020</verification_date>
  <study_first_submitted>April 10, 2017</study_first_submitted>
  <study_first_submitted_qc>April 20, 2017</study_first_submitted_qc>
  <study_first_posted type="Actual">April 25, 2017</study_first_posted>
  <last_update_submitted>July 21, 2020</last_update_submitted>
  <last_update_submitted_qc>July 21, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">July 23, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Aneuploidy</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

